Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 S Landmark Ave
Bloomington, IN 47403Phone+1 812-333-5973
Summary
- Dr. Thomas Lu is a gastroenterologist in Bloomington, IN and is affiliated with Indiana University Health - Bloomington. He received his medical degree from University of Cincinnati College of Medicine and completed his Internal Medicine residency and Gastroenterology fellowship training at the University of Chicago Medicine. He specializes in inflammatory bowel disease.
Education & Training
- University of ChicagoFellowship, Gastroenterology, 2015 - 2019
- University of ChicagoResidency, Internal Medicine, 2013 - 2015
- University of Cincinnati College of MedicineClass of 2013
Certifications & Licensure
- IL State Medical License 2013 - 2026
- IN State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 78 citationsA New Model of Spontaneous Colitis in Mice Induced by Deletion of an RNA m6A Methyltransferase Component METTL14 in T Cells.Thomas X. Lu, Zhong Zheng, Linda Zhang, Hui-Lung Sun, Marc Bissonnette
Cellular and Molecular Gastroenterology and Hepatology. 2020-01-01 - 335 citationsIL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.Carine Blanchard, Melissa K. Mingler, María Vicario, J. Pablo Abonia, Yi Ying Wu
The Journal of Allergy and Clinical Immunology. 2007-12-01 - 32 citationsEpigenetic Regulation of the IL-13-induced Human Eotaxin-3 Gene by CREB-binding Protein-mediated Histone 3 Acetylation *Eun Jin Lim, Thomas X. Lu, Carine Blanchard, Marc E. Rothenberg
The Journal of Biological Chemistry. 2011-04-15
Journal Articles
- The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controll...Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba, Gut, 12/17/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: